Potential drug–drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study

Potential drug–drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study

Objective The study was conducted to assess potential drug–drug interactions (PDDIs) and its determinants among patients with cancer receiving chemotherapy.Design and setting An institutional-based cross-sectional study was used. This study was conducted from 1 June 2021 to 15 December 2021, in Nort...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eyayaw Ashete Belachew, Fasil Bayafers Tamene, Samuel Agegnew Wondm, Kale Gubae, Samuel Berihun Dagnew, Asres Agegnehu Worku
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-12-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/13/12/e077863.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Simulated client study on the dispensing practices for narcotic and psychotropic medications in community drug outlets in Ethiopia
by: Tirsit Ketsela Zeleke, et al.
Published: (2025-07-01)

Polypharmacy and associated factors among patients with type two diabetes mellitus with comorbidity: a multicenter cross-sectional study in Northwest Ethiopia
by: Fasil Bayafers Tamene, et al.
Published: (2025-07-01)

Mental health treatment and its impact on survival outcomes in patients with comorbid mental health and cardiovascular diseases: a retrospective cohort study
by: Tirsit Ketsela Zeleke, et al.
Published: (2025-07-01)

Evaluation of deep vein thrombosis prophylaxis use in a Northwest Ethiopian medical ward: an observational follow-up study
by: Samuel Berihun Dagnew, et al.
Published: (2025-03-01)

Off-Label Drug Use in Oncology
by: E. V. Karabina, et al.
Published: (2022-07-01)

Quality of work life and related factors among community pharmacists in Northwest Amhara, Ethiopia multi centered cross sectional study
by: Abraham Nigussie Assefa, et al.
Published: (2025-07-01)

Clinical pharmacists’ interventions about drug therapy problems and its acceptability by prescribers among pediatric hospitalized patients with infectious diseases in resource-limited settings
by: Tilaye Arega Moges, et al.
Published: (2025-04-01)

Right to health in the court of justice: demand for oncology drugs
by: Ítala Paris de Souza, et al.
Published: (2012-08-01)

Pharmacotherapy of Oncological Diseases: Search for New Drugs and Approaches
by: M. V. Belova
Published: (2023-05-01)

New opportunities for accessing promising non-oncological orphan drugs
by: Carla E.M. Hollak, et al.
Published: (2025-05-01)

ASSORTMENTS OF DRUGS AND TECHNOLOGICAL RECEIVES, WHICH THE FIRST DOCTORS APPLIED
by: K. S. Guzev
Published: (2019-01-01)

Herb-drug interactions in oncology: pharmacodynamic/pharmacokinetic mechanisms and risk prediction
by: Xiaoyan Duan, et al.
Published: (2025-07-01)

Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment
by: Yu. V. Dinikina, et al.
Published: (2024-01-01)

Does mass drug administration affect Schistosoma mansoni infection trends in West Dembia district, Northwest Ethiopia?
by: Ayalew Jejaw Zeleke, et al.
Published: (2020-06-01)

Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs
by: Keiko Yamamoto, et al.
Published: (2025-08-01)

<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Polymicellar-based drug delivery systems for use in nanodentistry, oral and cranio-maxillo-facial oncology
by: Ziyad S Haidar
Published: (2023-03-01)

Synthesis, characterization and therapeutic advancements in cyclodextrin-based drug delivery systems for oncology: a review
by: Wanjie Zhang, et al.
Published: (2025-06-01)

Oncological outcomes of patients with ductal adenocarcinoma of the prostate receiving radical prostatectomy or radiotherapy
by: Mengzhu Liu, et al.
Published: (2021-04-01)

Renal drug dosing practices and clinical outcomes in patients with kidney disease admitted at two referral hospitals in Northwest Ethiopia
by: Gebeyaw Addis Bezie, et al.
Published: (2025-08-01)

Applications of Nanotechnology in Drug Delivery Systems
by: Humphrey Samuel, et al.
Published: (2024-09-01)

Prevalence and determinants of antidepressant non-adherence among patients with major depressive disorder in Ethiopia: a multi-center cross sectional study
by: Gashaw Sisay Chanie, et al.
Published: (2025-08-01)

Dynamics of T- and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs
by: A. V. Martynova, et al.
Published: (2022-02-01)

Optimizing TPD-based oncology drug development: the critical role of PDR distribution in POI-positive cancer cells
by: Xinyi Tao, et al.
Published: (2025-04-01)

Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials
by: Samuel Dinerman, et al.
Published: (2025-01-01)

Investigating the safety of physical rehabilitation with critically ill patients receiving vasoactive drugs: An exploratory observational feasibility study.
by: Huw R Woodbridge, et al.
Published: (2025-01-01)

Optimization of antiaggregant therapy in rheumatoid arthritis and coronary heart disease patients receiving nonsteroidal anti-inflammatory drugs
by: Tatyana Vladimirovna Kropotina, et al.
Published: (2012-08-01)

Materials of X Russian oncology congress, plenary session «New drugs in oncohematology» and other lectures on problems of hematologic malignancies
Published: (2022-11-01)

Non-prescribed drug use and its associated factors among pregnant women in Southwest Ethiopia
by: Fentahun Yene, et al.
Published: (2025-07-01)

Illicit drugs use in South African female correctional centres
by: Caroline Agboola, et al.
Published: (2024-12-01)

COMPARATIVE ANALYSIS OF THERAPY OUTCOMES IN PATIENTS WITH WEST SYNDROME RECEIVING TETRAСOSACTIDЕ AND OTHER ANTIEPILEPTIC DRUGS
by: M. E. Farnosova, et al.
Published: (2017-12-01)

THE ROLE OF HEREDITARY DISORDERS OF METABOLISM of FOLIC ACID IN THE DEVELOPMENT OF CONGENITAL DEFECT FETUS IN WOMEN WITH EPILEPSY AND RECEIVING ANTIEPILEPTIC DRUGS
by: D. V. Dmitrenko, et al.
Published: (2016-05-01)

Pantoprazole – safety in drug-drug interaction
by: E. V. Shikh, et al.
Published: (2012-09-01)

Case report: lichen planus in a patient with ulcerative colitis receiving sulfasalazine: a drug effect or a disease manifestation?
by: Ahmed Mohamed Nefzi, et al.
Published: (2025-12-01)

Anthelmintic efficiency of medicinal forms of albendazole received on mechanochemical technologies and use of address delivery Drug Delivery System on laboratory model
by: I. I. Glamazdin, et al.
Published: (2016-05-01)

Quality of Youth‐Friendly Service and Associated Factors at the Public Health Facilities of Awi Zone, Northwest Ethiopia: A Mixed Study
by: Gashaw Alamineh, et al.
Published: (2025-07-01)

Drug Abuse: perspectives on drugs /
by: Kaplan, Robert, 1925-
Published: (1970)

InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs
by: Aili Zhang, et al.
Published: (2025-07-01)

Ethosome-Based Transdermal Drug Delivery: Its Structural Components, Preparation Techniques, and Therapeutic Applications Across Metabolic, Chronic, and Oncological Conditions
by: Rashed M. Almuqbil, et al.
Published: (2025-04-01)

Influence of Dietary Diversity and Its Associated Factors Among Human Immunodeficiency Virus–Infected Adult Patients Receiving Antiretroviral Therapy in Northwest Ethiopia
by: Yihenew Sewale, et al.
Published: (2025-01-01)